Angola Launches Aspiring HPV Vaccination Campaign to Combat Cervical Cancer
Angola is undertaking one of the largest public health initiatives in its history, launching a nationwide vaccination campaign against the Human Papillomavirus (HPV) – the primary cause of cervical cancer – with the goal of protecting over two million girls aged 9 to 12 between October 27 and November 7.
A Critical Step in Women’s Health
Cervical cancer represents a significant health crisis in Angola, ranking among the leading causes of death for women of reproductive age. The World Health Organization (WHO) estimates over 2,000 new cases are diagnosed annually, with a devastating mortality rate of 50%. However, this disease is largely preventable, and the HPV vaccine offers a powerful line of defense. Each dose administered represents a crucial shield against a preventable tragedy.
Nationwide Rollout and Accessibility
To reach this ambitious goal, 1,667 teams from the Expanded Program on Immunization will be deployed across the country. These teams will visit public and private schools, health facilities, and communities, ensuring that 70% of eligible girls receive the vaccine free of charge. The vaccine will be administered as a single dose, aligning with current WHO guidelines.
Aligning with Global Health Goals
This campaign positions Angola at the forefront of the Global Strategy for the Elimination of Cervical Cancer, a key component of the Lasting Development goals and the pursuit of Universal Health Coverage. “Each dose is a victory against the disease, an investment in the future, and protection for Angolan families,” stated a senior representative from the WHO.
The official launch took place in Namibe province, where a United Nations official declared, “Angola is taking a historic step to protect its girls and ensure a healthier future.”
A Decade of Preparation Culminates in Action
The launch of this vaccination program is the result of 16 years of dedicated preparation and collaboration involving national authorities, health partners, civil society organizations, and the private sector. “this is an unprecedented joint effort in the history of public health in the country. Today, we are realizing the dream of protecting young Angolan women against cervical cancer,” explained the country’s Health Minister.
The campaign is also championed by the First Lady of the Republic, Dr. Ana Dias Lourenço, who serves as the national ambassador, mobilizing support from institutions, leaders, and communities to ensure comprehensive coverage.
WHO’s 2030 Vision for Cervical cancer Elimination
HPV vaccination in Angola is integral to the WHO’s broader strategy to eradicate cervical cancer as a public health problem by 2030.This ambitious plan hinges on achieving three key targets: vaccinating 90% of girls before the age of 15, ensuring 70% of women undergo regular screening for early detection, and providing appropriate treatment to 90% of those diagnosed.
Collaborative Effort and Strategic Partnerships
The operation is jointly led by the Ministries of health and Education, with vital technical and logistical support from the WHO, UNICEF, UNDP, GAVI, the European Union, the European Investment Bank, and other strategic partners. The WHO played a particularly crucial role in supporting the Goverment of Angola by conducting studies on factors influencing vaccine acceptance, developing a comprehensive communication strategy, and preparing essential implementation resources.
Now, the mission is clear: inform, mobilize, and act to vaccinate all girls, everywhere. The WHO is urging parents, teachers, community leaders, journalists, and influencers to disseminate accurate information and actively encourage vaccination.
